A new study, presented recently at the Federation of European Neuroscience Societies (FENS) Forum 2026 in Barcelona, Spain, uncovers genetic changes in brain cells that might help us understand why Parkinson’s is much more prevalent in males.
Parkinson’s is the second-most prevalent neurodegenerative condition, affecting around 1% of people aged over 60. Due to many factors, including our increasing average age, the number of Parkinson’s cases is projected to reach approximately 9 million by 2030, doubling cases since 2005.
These figures are concerning, and given that current treatments are far from perfect, understanding the disease as much as possible is vital.
Males are around 1.5 times more likely to develop Parkinson’s disease than females. Additionally, females tend to develop the condition later than males and survive for longer.
These differences could be due to a range of factors, including an increased likelihood of men experiencing head injuries or exposure to pesticides, solvents, and metals.
Read more:Two-time Ballon d’Or winner Alexia Putellas joins WSL side London City Lionesses
However, it is still an open question, and the latest study helps us begin to answer it.
The new study approaches the condition from a new angle. “The most interesting aspect is that the researchers are examining Parkinson’s disease through the lens of biological sex and glial cells, rather than focusing only on neurons,” Laura Bojarskaite, PhD, told Medical News Today. Bojarskaite, who was not involved in the study, is a neuroscientist and postdoctoral fellow at the University of Oslo.
In particular, the researchers investigated epigenetics and their potential role in the sex differences seen in Parkinson’s. Epigenetic changes are not changes to the DNA code; rather, they are modifications that switch genes “on” or “off.”
The most well-studied form of epigenetic modification is methylation, in which a methyl group is added to DNA, effectively switching it“off” or “silencing” it.
Lead author Prof. Julia Schulze-Hentrich’s previous research showed that females with Parkinson’s had changes to DNA methylation in 69 regions of their genome. In males, however, only two regions were affected.
Read more:World Cup Daily live: Ramos with winner over Croatia to send Portugal to last 16
As she explains, this suggests “that a person’s genetic make-up influences these DNA methylation changes.” This spurred her to investigate what specifically might influence differences in DNA methylation patterns between males and females.
Schulze-Hentrich and her colleagues collected brain samples from deceased people. In total, there were 73 people with Parkinson’s (28 females and 45 males). They compared these samples with 24 individuals without Parkinson’s (9 females and 15 males).
The scientists measured differences in gene expression across all brain cell types in five regions. This includes neurons, which transmit messages, and glial cells, which are multi-functional support cells for neurons. Glial cells include astrocytes, oligodendrocytes, and microglia.
“We studied five brain regions and found that Parkinson’s causes common changes in the brain, regardless of sex,” explains Schulze-Hentrich. “
“All these cells in the five regions,” she continued, “showed signs of being under stress. They switched on proteins that help damaged proteins fold correctly, called ‘chaperones.’”
Read more:Liver cancer: 5+ cups of coffee a day linked to nearly 50% lower risk
Interestingly, they also found differences in gene activity between males and females, in some cells and some brain regions.
Schulze-Hentrich and her team identified differences in gene activity between the sexes, including:
“This shows that Parkinson’s triggers some shared ‘stress responses’ in everyone’s brain cells,” explains Schulze-Hentrich, “but also, there are differences between men and women at the cellular level, especially in how the brain ‘support’ cells manage energy and protect nerve connections.”
She explains how their findings “help to explain why symptoms and disease progression in Parkinson’s differ between men and women.”
Read more:Sources: Crystal Palace readying offer for Lens coach Sage
She hopes that this could, eventually, lead to personalized Parkinson’s treatments, “rather than treating all patients with Parkinson’s as biologically identical.”
Speaking to MNT, Dr. Kang Hsu, Chief Medical Officer (CMO) of Canary Speech, said, “What stands out most to me is that women with Parkinson’s showed stronger blood‑based gene‑switch changes than men, even though men get Parkinson’s more often.” Hsu was not involved in the research.
In the past, much of the research on Parkinson’s disease has focused only on neurons or on males (humans or animals). Schulze-Hentrich hopes that future researchers will cast their net a little wider, helping us better understand the individual differences in how this condition develops and progresses.
This study adds a small piece to the huge, sprawling jigsaw that is Parkinson’s disease. Despite the condition being named well over 100 years ago, we are still far from a cure, and existing treatments are still limited.
MNT asked neurologist, Dr. Rab Nawaz Khan, who was not involved in the study, why Parkinson’s is so challenging to study:
Read more:Women’s Champions League final recap: Four goals in second half gives Barça fourth title
“Parkinson’s likely begins years before the classic movement symptoms appear, making it difficult to know when the disease truly started or which exposures mattered most.”
“It is also a very heterogeneous condition,” he continued, “two people can have different symptoms, rates of progression, genetic backgrounds, and environmental histories.” Plus, he explains, “We still lack a simple, definitive test that can identify every case early.”
“Environmental exposures, inflammation, and lifestyle all contribute to risk, but their relative importance differs between individuals. Rather than being caused by a single factor. Parkinson’s likely results from the interaction of many biological and environmental influences, making it difficult to pinpoint clear causes.”
— Laura Bojarskaite, PhD
So, while the new study adds to our understanding, we still have a long journey ahead of us.
